BioHarvest Sciences Inc(BHST) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 6:04 AM ET (Korea 9/11 19:04)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.52 | Insider Own | 16.12% | Shs Outstand | 22.7M | Perf Week | -1.58% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | 36.49% | Insider Trans | - | Shs Float | 14.5M | Perf Month | -9.88% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.14 | Inst Own | 9.71% | Short Float | 0.5% | Perf Quarter | -39.48% |
| Income | -0.01B | P/S | 1.19 | EPS this Y | 12.08% | Inst Trans | -0.4% | Short Ratio | 1.42 | Perf Half Y | -54.94% |
| Sales | 0.04B | P/B | 2.14 | EPS next 5Y | - | ROA | -30.6% | Short Interest | 0.07M | Perf YTD | -63.97% |
| Book/sh | 0.87 | P/C | 2.61 | EPS past 3/5Y | 11.1% 2.26% | ROE | -142.5% | 52W High | -85.39% ($12.80) | Perf Year | -74.73% |
| Cash/sh | 0.72 | P/FCF | - | Sales past 3/5Y | 84.46% 144.37% | ROIC | -33.66% | 52W Low | 3.89% ($1.80) | Perf 3Y | -59.89% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 24.63% | Gross Margin | 58.95% | Volatility(W/M) | 6.97% 7.97% | Perf 5Y | -82.96% |
| Dividend TTM | - | EV/Sales | 1.23 | Sales Y/Y TTM | 17.5% | Oper. Margin | -17.99% | ATR (14) | 0.17 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 1.75 | EPS Q/Q | 30.37% | Profit Margin | -31.21% | RSI (14) | 38.94 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.24 | Sales Q/Q | 3.78% | SMA20 | -4.43% ($1.96) | Beta | 1.36 | Target Price | $10.5 |
| Payout | - | Debt/Eq | 0.89 | Earnings | 2026/8/11 | SMA50 | -17.09% ($2.26) | Rel Volume | 0.26 | Prev Close | $1.8 |
| Employees | 89 | LT Debt/Eq | 0.66 | EPS/Sales Surpr. | -44.68% -6.5% | SMA200 | -52.91% ($3.97) | Avg Volume(3M) | 0.05M | Price | $1.87 |
| IPO | 2019/3/8 | Option/Short | No/Yes | Trades | 71 | Volume | 13,613 | Change | 3.89% |
Company
BHST is a Consumer Defensive sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🌿 An innovative biotech company that produces high-value plant-derived compounds through its proprietary 'Plant Cell Cultivation (Bio-Plant CELLicitation™)' technology. The company has successfully commercialized 'VINIA®', a health functional food that maximizes the concentration of active ingredients by proliferating plant cells directly in bioreactors without traditional agricultural methods.
Over the past 1 year, on the lower side
85% below its 1-year high.
BHST has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Earnings are growing steadily
Earnings are expected to grow by +12.1% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Slight tendency to beat estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Would have changed by -59.9% if bought 5 years ago.
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 9.7%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
AIMS 0.00%It ranks #4 in the industry
Based on market cap of $42M.
BHST $42M PER -
KHC $29B PER -
GIS $19B PER -
MKC $14B PER 8.5
FAQ
What kind of company is BHST?
BHST belongs to the Consumer Defensive sector and operates in the Packaged Foods industry.
What is the market cap of BHST?
The market cap of BHST is approximately $42M, ranking 5,008 within its sector.
What is the 52-week high and low for BHST?
BHST has recorded a 52-week high of $12.80 and a low of $1.80.
